The Oncology Institute (TOI)
(Delayed Data from NSDQ)
$0.29 USD
0.00 (1.19%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $0.29 0.00 (0.55%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
The Oncology Institute, Inc. (TOI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$2.00 | $2.00 | $2.00 | 589.66% |
Price Target
Only one analyst offered a short-term price target of $2.00 for The Oncology Institute, Inc. This represents an increase of 589.66% from the last closing price of $0.29.
Analyst Price Targets (1 )
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for The Oncology Institute, Inc. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 1.00 a month ago based on just one Strong Buy recommendation.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/TOI.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/26/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 1 |
Average Target Price | $2.00 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 175 of 253 |
Current Quarter EPS Est: | -0.06 |
TOI FAQs
The Oncology Institute, Inc. (TOI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 1 brokerage firms.
The average price target for The Oncology Institute, Inc. (TOI) is $2.00. The current on short-term price targets is based on 1 reports.
The forecasts for The Oncology Institute, Inc. (TOI) range from a low of $2 to a high of $2. The average price target represents a increase of $589.66 from the last closing price of $.29.
The current UPSIDE for The Oncology Institute, Inc. (TOI) is 589.66%
Only one analyst offered a short-term price target of $2.00 for The Oncology Institute, Inc. This represents an increase of 589.66% from the last closing price of $0.29.